NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCATS E-244-2014-0-US-11 Small Molecule Inhibitors Of Lactate Dehydrogenase US CON 17/160,868 11247971 Issued PDF
NCI E-141-2021-0-US-01 LIQUID BIOPSY TO DETECT CANCER EARLY AND SENSITIVELY IN PATIENTS WITH NEUROFIBROMATOSIS TYPE 1 US 63/142,207 Abandoned
NCI E-041-2020-0-PCT-02 RAB13 AND NET1 ANTISENSE OLIGONUCLEOTIDES TO TREAT METASTATIC CANCER PCT PCT PCT/US2021/015053 Expired
NCI E-256-2020-0-US-01 IMIDAZO[1,2-a]PYRAZINE AND IMIDAZO[1,2-a]PYRIDINE BASED TYROSYL-DNA PHOSPHODIESTERASE I (TDP1) INHIBITORS US 63/141,634 Abandoned
NIDCD E-029-2020-0-PCT-02 USE OF STATINS TO TREAT OR PREVENT DRUG INDUCED HEARING LOSS PCT PCT PCT/U2021/014918 Expired
NIDCD E-029-2020-0-EP-03 USE OF STATINS TO TREAT OR PREVENT DRUG INDUCED HEARING LOSS EP National Stage 21705831.2 Pending
NIAID E-099-2016-1-US-23 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS US CON 17/157,761 Abandoned
NCI E-031-2014-0-US-10 PCSK9 VACCINE AND METHODS OF USING THE SAME US CON 17/155,549 11696941 Issued PDF
NCATS E-116-2016-0-US-09 CRYSTAL FORMS AND METHODS OF SYNTHESIS OF (2R, 6R)-HYDROXYNORKETAMINE AND (2S, 6S)-HYDROXYNORKETAMINE US DIV 17/155,162 11613514 Issued PDF
NIDCD E-004-2019-1-PCT-02 ADENO-ASSOCIATED VIRUSES AND THEIR USES FOR INNER EAR THERAPY PCT PCT PCT/US2021/014553 Expired
NCI E-181-2018-2-US-04 OXYNITIDINE DERIVATIVES USEFUL AS INHIBITORS OF TOPOISOMERASE IB (TOP1) AND TYROSYL-DNA PHOSPHODIESTERASE 1 (TDP1) US National Stage 17/262,379 Pending
NIDCD E-004-2019-1-CN-04 ADENO-ASSOCIATED VIRUSES AND THEIR USES FOR INNER EAR THERAPY CN National Stage 202180002375.X Pending
NIDCD E-004-2019-1-EP-05 ADENO-ASSOCIATED VIRUSES AND THEIR USES FOR INNER EAR THERAPY EP National Stage 21706093.8 Pending
NIDCD E-004-2019-1-IL-06 ADENO-ASSOCIATED VIRUSES AND THEIR USES FOR INNER EAR THERAPY IL National Stage 285977 Pending
NIAID E-196-2022-0-US-01 Compositions And Methods For Treating Malaria US 63/140,308 Abandoned
NCI E-233-2014-0-AU-09 Methods of isolating T cell receptors having antigenic specificity for a cancer specific mutation AU DIV 2021200388 Issued
NEI E-164-2018-3-AU-02 INTRAOCULAR DELIVERY OF GENE THERAPY EXPRESSION VECTORS AU National Stage 2019307911 Issued
NCI E-159-2019-0-PCT-02 HUMAN IMMUNOGENIC EPITOPES OF HEMO and HHLA2 HUMAN ENDOGENOUS RETROVIRUSES (HERVS) PCT PCT PCT/US2021/014335 Expired
NCI E-170-2019-0-PCT-02 HUMAN IMMUNOGENIC EPITOPES OF H, K, AND E HUMAN ENDOGENOUS RETROVIRUSES (HERVs) PCT PCT PCT/US2021/014360 Expired
NIAID E-068-2021-0-US-01 NEWCASTLE DISEASE VIRUS-LIKE PARTICLE DISPLAYING PREFUSION-STABILIZED SARS-COV-2 SPIKE AND ITS USE US 63/140,250 Abandoned
NIAID E-050-2018-0-US-07 NIPAH VIRUS IMMUNOGENS AND THEIR USE US National Stage 17/261,828 11890339 Issued PDF
NCI E-169-2018-0-PCT-02 ARYL HYDANTOIN HETEROCYCLES AND METHODS OF USE PCT PCT PCT/US2021/014176 Expired
NEI E-164-2018-3-JP-05 INTRAOCULAR DELIVERY OF GENE THERAPY EXPRESSION VECTORS JP National Stage 2021-503027 Issued
NIAID E-081-2013-4-CN-16 Prefusion RSV F Proteins And Their Use CN DIV 202110068562.X Pending
NEI E-164-2018-3-CA-03 INTRAOCULAR DELIVERY OF GENE THERAPY EXPRESSION VECTORS CA National Stage 3106869 Pending
NIDDK E-051-2021-0-US-01 Heterocyclic P2Y14 Antagonists US 63/138,581 Abandoned
NEI E-008-2020-0-PCT-02 GENE THERAPY FOR TREATMENT OF CRX-AUTOSOMAL DOMINANT RETINOPATHIES PCT PCT PCT/US2021/013733 Expired
NHLBI E-070-2020-0-PCT-02 ISOTOPES OF ALPHA KETOGLUTARATE AND RELATED COMPOUNDS FOR HYPERPOLARIZED IMAGING PCT PCT PCT/US2021/013658 Expired
NHLBI E-069-2020-0-PCT-02 REAL-TIME MONITORING OF IN VIVO FREE RADICAL SCAVENGERS THROUGH HYPERPOLARIZED N-ACETYL CYSTEINE ISOTOPES PCT PCT PCT/US2021/013634 Expired
NEI E-164-2018-3-US-06 INTRAOCULAR DELIVERY OF GENE THERAPY EXPRESSION VECTORS US National Stage 17/260,905 Pending
NHLBI E-070-2020-0-EP-03 ISOTOPES OF ALPHA KETOGLUTARATE AND RELATED COMPOUNDS FOR HYPERPOLARIZED IMAGING EP National Stage 21741941.5 Pending
NEI E-008-2020-0-EP-06 GENE THERAPY FOR TREATMENT OF CRX-AUTOSOMAL DOMINANT RETINOPATHIES EP National Stage 21705324.8 Pending
NHLBI E-069-2020-0-EP-03 REAL-TIME MONITORING OF IN VIVO FREE RADICAL SCAVENGERS THROUGH HYPERPOLARIZED N-ACETYL CYSTEINE ISOTOPES EP National Stage 21741034.9 Pending
NEI E-008-2020-0-JP-07 GENE THERAPY FOR TREATMENT OF CRX-AUTOSOMAL DOMINANT RETINOPATHIES JP National Stage 2022-540642 Pending
NIAID E-055-2021-0-US-01 REPLICATION-COMPETENT ADENOVIRUS TYPE 4 SARS-COV-2 VACCINES AND THEIR USE US 63/138,221 Abandoned
NCI E-050-2021-0-US-01 SONIC-HEDGEHOG INHIBITORS FOR TREATMENT OF COVID-19 US 63/138,106 Abandoned
NEI E-008-2020-0-AU-04 GENE THERAPY FOR TREATMENT OF CRX-AUTOSOMAL DOMINANT RETINOPATHIES AU National Stage 2021208631 Pending
NCATS E-026-2016-0-BR-20 Compounds for Improving MRNA Splicing BR DIV BR122021000819-1 Pending
NEI E-008-2020-0-CA-05 GENE THERAPY FOR TREATMENT OF CRX-AUTOSOMAL DOMINANT RETINOPATHIES CA National Stage 3165922 Pending
NHLBI E-070-2020-0-IL-04 ISOTOPES OF ALPHA KETOGLUTARATE AND RELATED COMPOUNDS FOR HYPERPOLARIZED IMAGING IL National Stage 294464 Pending
NHLBI E-069-2020-0-IL-04 REAL-TIME MONITORING OF IN VIVO FREE RADICAL SCAVENGERS THROUGH HYPERPOLARIZED N-ACETYL CYSTEINE ISOTOPES IL National Stage 294365 Pending
NCI E-011-2019-1-US-02 CELL LINKERS FOR HETEROTYPIC CELL SPHEROIDS US National Stage 17/260,365 Issued
NHLBI E-143-2021-1-US-02 Tissue Cutting Systems and Methods US ORD 17/148,170 11337753 Issued PDF
NIDA E-109-2019-0-PCT-02 FENTANYL HAPTENS FOR THE PREPARATION OF A FENTANYL VACCINE PCT PCT PCT/US2021/013300 Expired
NCI E-275-2014-0-US-12 FUROQUINOLINEDIONES AS INHIBITORS OF TDP2 US CON 17/146,327 11999747 Issued PDF
NCI E-161-2018-0-US-07 AFFINITY MATURED CD22-SPECIFIC MONOCLONAL ANTIBODY AND USES THEREOF US National Stage 17/259,334 11939377 Issued PDF
NCI E-154-2018-0-US-06 BINARY LIPID BILAYER-CONTAINING VESICLES COMPRISING EMBEDDED CYTOTOXIC AGENTS AND METHODS OF MAKING AND USING THE SAME US National Stage 17/259,499 Pending
NEI E-033-2021-0-US-01 EXOSOMES COMPRISING IL-35 OR IL-27 AND USES THEREOF US 63/135,833 Abandoned
NIBIB E-237-2020-0-US-01 SYSTEMS AND METHODS FOR PRODUCING ISOTROPIC IN-PLANE SUPERRESOLUTION
IMAGES FROM LINE-SCANNING CONFOCAL MICROSCOPY 		US 63/134,907 Abandoned
NCI E-091-2019-0-PCT-02 METHOD OF PRODUCING T CELL POPULATIONS USING INDUCED PLURIPOTENT STEM CELLS PCT PCT PCT/US2021/012444 Expired